Skip to main content

Table 1 Usual arrangements versus Patient-Initiated Follow-Up (PIFU) in the rheumatology outpatient clinic

From: Patient-Initiated Follow-Up (PIFU) as reorganized support for increased patient involvement – focus group discussions among patients’ with inflammatory arthritis

Care and services offered to patients with IAa

Treatment characteristic

1) Conservative or unlicensed medicine (p.o.b)

2) Licensed medicine (p.o., s.c.c)

3) Drug infusion

Model of follow-up care

Usual

Patient-Initiated Follow-Up (PIFU)

1)

2)

3)

1)

2)

3)

Disease monitoring

Blood test

Every 8–12 weeks

PROMd (DANBIO)e

Self-reported, on-site ahead of any consultation and/or drug infusion

Rheumatologist consultation

Traditional medical consultation (15 min)

Fixed, planned every third to fourth month

Annual

Acute consultation

Significant waiting time (5–8 days)

Usual rheumatologist within five working days or any rheumatologist within 1–2 days

Nurse-led clinic

Individual nurse consultation (45 min, approximately six months offset from the medical consultation)

Not offered (NO)

Annual nurse consultation; aiming to cover the patient’s knowledge of his/her actual situation, preferences and needs and includes screening for cardiovascular risk factors

Telephone support

Direct telephone to a nurse on weekdays from 1 to 3 pm and a secretary 8–12 am who can leave a message for a nurse or renew prescriptions

Hotline, manned on weekdays 8 am to 3 pm by an experienced RRNf

Drop-in function (e.g. dispensing or administration of medicines and self-administration training)

NO

Medication pickup with an interval of eight weeks (e.g., prefilled syringes)

NO

NO

As usual

NO

Infusion room (Manned with 2–3 nurses on weekdays from 8 am - 3 pm)

NO

NO

Drug infusion (30–60 min) administered by a nurse every 6–8 weeks

NO

NO

As usual

Delegated tasks (e.g, I.M.ginjections, drug information, planning of treatment and laboratory test, infection detection)

As usual

  1. Abbreviations: aIA rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, bp.o per os, cs.c. subcutaneous, dPROM Patient-reported outcome measures, eDANBIO The Danish nationwide clinical register for patients with reheumatoid arthritis, fRRN Registered Rheumatology Nurse (educated between 1983 and 2005 with an average of 17 years of experience within rheumatology), gI.M. intramuscular, NO Not Offered